Article
Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and developmental outcomes.
The Journal of pediatrics - 1 Jan 2000
Rouse B, Matalon R, Koch R, Azen C, Levy H, Hanley W, Trefz F, de la Cruz F
Abstract excerpt
OBJECTIVE: A cohort of women with phenylketonuria (PKU) were selected to explore the impact of phenylalanine (Phe) levels and other factors on congenital heart defects (CHDs), microcephaly, and development of their offspring. STUDY DESIGN: Three hundred fifty-four women with PKU were followed up weekly with diet records, blood Phe levels, and sonograms obtained at 18 to 20 and 32 weeks' gestation. At birth, 413...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
